New Zealand markets open in 6 hours 18 minutes

Bayer Aktiengesellschaft (BAYZF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
48.20+0.95 (+2.01%)
As of 09:39AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close47.25
Bid0.00 x 0
Ask0.00 x 0
Day's range48.20 - 48.20
52-week range46.12 - 74.34
Avg. volume11,092
Market cap47.653B
Beta (5Y monthly)1.15
PE ratio (TTM)11.50
EPS (TTM)4.19
Earnings dateN/A
Forward dividend & yield2.11 (4.55%)
Ex-dividend date02 May 2022
1y target estN/A
  • Zacks

    Roche's (RHHBY) Vabysmo Gets Approval for nAMD & DME in Europe

    The European Commission approves Roche's (RHHBY) Vabysmo for treating neovascular or wet age-related macular degeneration and visual impairment due to diabetic macular edema.

  • Bloomberg

    Bayer Begins Search for New Chief Executive Officer

    (Bloomberg) -- Most Read from BloombergUS Inflation Tops Forecasts, Cementing Odds of Big Fed HikeUgly Selloff Pushes Stocks Down Most Since 2020: Markets WrapTerra Co-Founder Do Kwon Faces Arrest Warrant in South KoreaXi Returns to World Stage With Putin to Counter US DominanceThese Cities Have the Most Millionaires in New RankingBayer AG has quietly started the search for a successor to Chief Executive Officer Werner Baumann, raising the prospect of an early departure, according to people fami

  • Zacks

    Regeneron (REGN) Up on Higher Dose Eye Drug Studies Success

    Regeneron (REGN) stock jumps as aflibercept 8 mg with 12- and 16-week dosing regimens in patients with DME and wAMD meet primary goals.